Aug 14, 2024 8:30am EDT RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Jul 31, 2024 8:30am EDT RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®
Jul 08, 2024 8:30am EDT RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®
Jun 26, 2024 8:30am EDT University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
Jun 10, 2024 8:30am EDT RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
May 21, 2024 9:00am EDT Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery
May 14, 2024 9:00am EDT RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
May 02, 2024 9:00am EDT RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024
